Immunohistochemical analysis of transforming growth factor-β3 expression in acquired reactive perforating collagenosis [10]

British Journal of Dermatology

Volumn 144, Issue 1, 2001, Pages 197-198

  Kawakami, T ^a   Soma, Y ^a   Mizoguchi, M ^a   Saito, R ^a,b  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN FIBER; CYTOKINE ANTIBODY; POLYCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA3;

ADULT; AGED; CLINICAL ARTICLE; COLLAGEN DISEASE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HISTOGENESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; MALE; PRIORITY JOURNAL; WOUND HEALING;

EID: 0035128984     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2001.03982.x     Document Type: Letter

References (8)

1. Acquired reactive perforating collagenosis: Report of six cases and review of the literature
2. Acquired reactive perforating collagenosis associated with diabetes mellitus: Eight cases that meet Faver's criteria
3. TGF-β3, but not TGF-β1, protects keratinocytes against 12-O-tetradecanoylphorbol-13-acetate-induced cell death in vitro and in vivo
4. Acquired reactive perforating collagenosis
5. Reactive perforating collagenosis (Mehregan): Report of two new cases and review of literature
6. Cell death by apoptosis in epidermal biology
7. In situ analysis of transforming growth factors-β (TGF-β1, TGF-β2, TGF-β3) and TGF-β type II receptor expression in basal cell carcinomas
8. Enhanced expression of transforming growth factor-β type I and type II receptors in wound granulation tissue and hypertrophic scar